CN Patent

CN101443015A — 具有改善的生物利用率的乙炔雌二醇及其药物前体的固体剂型的给药方法

Assigned to Warner Chilcott Co LLC · Expires 2009-05-27 · 17y expired

What this patent protects

通过给患者口服含有乙炔雌二醇或者其药物前体的固体剂型以改善乙炔雌二醇的生物利用率的方法，其中该剂型至少在口腔中释放部分乙炔雌二醇或者其药物前体，使其通过口腔粘膜吸收以治疗患者从而达到例如激素代替治疗或避孕的预定效果。固体剂型可以选自咀嚼片剂、速溶片、膜剂、溶解膜剂、粘膜粘着剂片、锭剂和口香糖。

USPTO Abstract

通过给患者口服含有乙炔雌二醇或者其药物前体的固体剂型以改善乙炔雌二醇的生物利用率的方法，其中该剂型至少在口腔中释放部分乙炔雌二醇或者其药物前体，使其通过口腔粘膜吸收以治疗患者从而达到例如激素代替治疗或避孕的预定效果。固体剂型可以选自咀嚼片剂、速溶片、膜剂、溶解膜剂、粘膜粘着剂片、锭剂和口香糖。

Drugs covered by this patent

Patent Metadata

Patent number
CN101443015A
Jurisdiction
CN
Classification
—
Expires
2009-05-27
Drug substance claim
No
Drug product claim
No
Assignee
Warner Chilcott Co LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.